One single biopsy not sufficient to guide treatment decisions in prostate cancer, say researchers

While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal. Genomic fingerprinting can help predict a tumor's aggressiveness and tailor treatment plans, report researchers.